The drug Trikafta has changed the lives of many Canadians living with cystic fibrosis. But in many other parts of the world, the drug is either not available — or if it is, it costs hundreds of thousands of dollars a year. That’s why Cheri Nel, who is based in Johannesburg, is suing American pharmaceutical company Vertex over its patent and price tag.
How to kill one million mice
The threat of ISIS-K
Human gets gene-edited pig kidney
Visa program ‘failing’ Palestinians with family in Canada
Sports need better funding to ensure safety, says Canadian Olympic Committee head
How the internet opened a ‘torrent of incoming generosity’
‘Kategate’ and the birth of celebrity conspiracies
N.L. fish harvesters call for more control of their sales
Why happiness rates are falling among younger generations
Searching for the ocean’s undiscovered species
Repairing Africa’s underwater link to the internet
The spiritual experience of witnessing a solar eclipse
What airdropping food, supplies into Gaza looks like from above
Controversy surrounding NDP’s Gaza motion, Liberal’s climate tax
Trusting your kids might discourage them from cheating, research finds
Opponents of diversity in gaming target Canadian consulting firm
Boreal forests move north as Arctic ice melts
The Current Introduces: The Pornhub Empire: Understood
What’s behind Putin’s re-election as Russia’s president
Feeling invisible? You might be languishing
Create your
podcast in
minutes
It is Free
Front Burner
Vinyl Cafe
Ideas
Someone Knows Something
Under the Influence with Terry O’Reilly